| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA623: Patiromer for treating hyperkalaemia |
|
Medicine details |
|
| Medicine name | patiromer (Veltassa®) |
| Formulation | 8.4 g, 16.8g and 25.2g powder for oral suspension |
| Reference number | 1991 |
| Indication | Treatment of hyperkalaemia in adult patients with advanced CKD (stage 3-4) on RAAS inhibitor treatment who develop hyperkalaemia |
| Company | Vifor Pharma UK Ltd |
| BNF chapter | Nutrition & blood |
| Assessment type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 24/05/2018 |
| NICE guidance | |